YAKHAK HOEJI
ISSN 0377-9556 (PRINT)
ISSN 2383-9457 (ONLINE)
ISSN 2383-9457 (ONLINE)
The number of serious adverse events of tocilizumab
| Serious adverse events | |
|---|---|
| number (%) | |
| Body as a whole-general disorders | 24 (6.3) |
| Anaphylactic reaction | 11 (2.9) |
| Fever | 3 (0.8) |
| Chest pain | 3 (0.8) |
| Skin and appendages disorders | 16 (4.2) |
| Rash | 6 (1.6) |
| Urticaria | 4 (1.1) |
| Pruritus | 4 (1.1) |
| Respiratory system disorders | 15 (4.0) |
| Dyspnoea | 6 (1.6) |
| Pneumonia | 5 (1.3) |
| Coughing | 2 (0.5) |
| Gastro-intestinal system disorders | 10 (2.6) |
| Nausea | 4 (1.1) |
| Abdominal pain | 3 (0.8) |
| Vomiting | 2 (0.5) |
| Resistance mechanism disorders | 6 (1.6) |
| Herpes zoster | 3 (0.8) |
| Sepsis | 2 (0.5) |
| Cardiovascular disorders, general | 5 (1.3) |
| Hypotension | 3 (0.8) |
| Application site disorders | 5 (1.3) |
| Cellulitis | 3 (0.8) |
| White cell and RES* disorders | 4 (1.1) |
| Leucopenia | 2 (0.5) |
| Granulocytopenia | 2 (0.5) |